Best Portal Hypertension Treatment Doctors in India
Dr. Murugan N
Whatsapp Us
Dr. (Col) Avnish Seth
Dr. Sanjiv Saigal
Dr. Charles Panackel
Dr. Mallikarjun Sakpal
Dr. Narendra Singh Choudhary
Dr. Geeta Malkan Billa
What Patients with Portal Hypertension Worry About Most
Portal hypertension is raised pressure in the portal venous system, almost always from cirrhosis. Patients worry about variceal bleeding, about ascites that needs repeated drainage, and about hepatic encephalopathy that affects work and family life. Many have already been admitted for a bleed or for tense ascites. The honest position is that portal hypertension is manageable with non-selective beta-blockers, endoscopic band ligation, sodium restriction, diuretics, and selected radiological procedures. Liver transplantation is the definitive cure when decompensation progresses, with excellent long-term outcomes.
How Portal Hypertension Is Diagnosed
Diagnosis is suggested by clinical features (splenomegaly, ascites, varices, low platelets, prominent abdominal wall veins) in a patient with chronic liver disease. Ultrasound with Doppler shows portal vein flow, splenomegaly, and ascites. Transient elastography assesses liver stiffness. Upper gastrointestinal endoscopy screens for oesophageal and gastric varices. Hepatic venous pressure gradient measurement is the gold standard, with values above ten millimetres of mercury defining clinically significant portal hypertension. Magnetic resonance and computed tomography portovenography map the venous anatomy before transjugular intrahepatic portosystemic shunt placement or surgery.
Treatment Options for Portal Hypertension in India
Treatment targets the consequences and, where possible, the cause. Non-selective beta-blockers (propranolol, carvedilol, nadolol) reduce portal pressure and lower variceal bleeding risk. Endoscopic band ligation manages oesophageal varices. Diuretics (spironolactone, furosemide) and salt restriction treat ascites. Large-volume paracentesis with albumin replacement is used for tense ascites. Lactulose and rifaximin treat hepatic encephalopathy. Transjugular intrahepatic portosystemic shunt is used for refractory variceal bleeding, refractory ascites, and selected complications. Balloon-occluded retrograde transvenous obliteration treats gastric varices. Treating the underlying cause (antiviral therapy for hepatitis B and hepatitis C, alcohol cessation, ursodeoxycholic acid for primary biliary cholangitis) can reverse early portal hypertension. Liver transplantation is the definitive cure. Institute of Liver and Biliary Sciences, Fortis Memorial Research Institute, Medanta, Apollo Hospitals, Asian Institute of Gastroenterology, and All India Institute of Medical Sciences run dedicated portal hypertension programmes.
Recovery, Success Rates, and Follow-Up
Non-selective beta-blockers reduce first variceal bleeding by around half. Endoscopic band ligation eradicates oesophageal varices in most patients with a structured programme. Transjugular intrahepatic portosystemic shunt has procedural success above ninety-five percent. Refractory ascites managed by transjugular intrahepatic portosystemic shunt improves quality of life and survival in selected patients. Liver transplantation has five-year survival above seventy-five percent. Long-term follow-up includes liver function, surveillance endoscopy, transient elastography, hepatocellular carcinoma screening every six months, and nutritional support.
How to Choose the Right Liver Unit for Portal Hypertension
Ask the centre whether twenty-four-hour endoscopy, interventional radiology for transjugular intrahepatic portosystemic shunt and balloon-occluded retrograde transvenous obliteration, hepatic venous pressure gradient measurement, and a liver transplant programme are all available in-house. Ask about volumes of variceal band ligation, transjugular intrahepatic portosystemic shunt insertion, and liver transplantation. Ask about the multidisciplinary cirrhosis clinic with hepatologist, transplant surgeon, dietitian, and palliative care input.
International Patient Support
International patients receive a single coordinator who arranges endoscopy, transjugular intrahepatic portosystemic shunt if needed, transplant evaluation, and long-term follow-up. The Cancer Rounds team supports medical visa invitation letters, accommodation, airport transfers, and multilingual support in eleven plus languages. Patients arrive from Nigeria, Bangladesh, Kenya, Ethiopia, Iraq, Oman, and the United Arab Emirates for portal hypertension care. A written long-term plan and cost estimate are shared before travel.
Frequently Asked Questions
What causes portal hypertension?
Cirrhosis from any cause is the commonest reason worldwide: hepatitis B, hepatitis C, alcohol, fatty liver disease, autoimmune liver disease, and biliary disease. Less common causes include portal vein thrombosis, schistosomiasis, and non-cirrhotic portal hypertension.
What is hepatic venous pressure gradient?
Hepatic venous pressure gradient is the pressure difference across the liver measured by catheter through the jugular vein. Values above ten millimetres of mercury define clinically significant portal hypertension and predict complications.
Is transjugular intrahepatic portosystemic shunt safe?
Transjugular intrahepatic portosystemic shunt is done by interventional radiology under sedation. Procedural success is above ninety-five percent. The main risk is hepatic encephalopathy, which is reversible with lactulose, rifaximin, and shunt adjustment if needed.
Can portal hypertension be reversed?
Treating the underlying cause early, such as hepatitis C cure with direct-acting antivirals, hepatitis B suppression, alcohol cessation, or weight loss for fatty liver disease, can lower portal pressure and partly reverse early disease. Advanced cirrhosis is harder to reverse but stabilises.
What is hepatic encephalopathy?
Hepatic encephalopathy is reversible brain dysfunction in advanced liver disease with confusion, sleep changes, asterixis, and tremor. Triggers include infection, bleeding, dehydration, and constipation. Treatment is lactulose, rifaximin, and addressing the trigger.
When is liver transplantation considered?
Liver transplantation is considered for decompensated cirrhosis with ascites, encephalopathy, variceal bleeding not controlled by other means, or hepatocellular carcinoma within criteria. The Model for End-Stage Liver Disease score guides timing. Outcomes are excellent.
